Two novel HLA-A alleles detected in a potential hematopoietic stem cell donors: HLA-A*03:418 and -A*26:220.


Journal

HLA
ISSN: 2059-2310
Titre abrégé: HLA
Pays: England
ID NLM: 101675570

Informations de publication

Date de publication:
02 2023
Historique:
revised: 02 10 2022
received: 15 09 2022
accepted: 03 10 2022
pubmed: 8 10 2022
medline: 21 1 2023
entrez: 7 10 2022
Statut: ppublish

Résumé

HLA-A*03:418 and -A*26:220, two novel alleles detected by next generation sequencing.

Identifiants

pubmed: 36205616
doi: 10.1111/tan.14843
doi:

Substances chimiques

HLA-A Antigens 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

151-153

Informations de copyright

© 2022 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Références

Robinson J, Barker DJ, Georgiou X, Cooper MA, Flicek P, Marsh SGE. IPD-IMGT/HLA Database. Nucleic Acids Res. 2020;48:D948-D955.
Marsh SGE, Albert ED, Bodmer WF, et al. Nomenclature for factors of the HLA system. Tissue Antigens. 2010;75:291-455.

Auteurs

Anastasiia Ananeva (A)

Institute of Fundamental Medicine and Biology, Kazan (Volga Region) Federal University, Kazan, Russian Federation.

Akhmetshina Gulnaz (A)

Institute of Fundamental Medicine and Biology, Kazan (Volga Region) Federal University, Kazan, Russian Federation.

Elena Shagimardanova (E)

Institute of Fundamental Medicine and Biology, Kazan (Volga Region) Federal University, Kazan, Russian Federation.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH